ANDREA THOMPSON: Open Payments
NPI 1508861865 · FAYETTEVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$484 in 21 payments from 10 companies in 2025. Trend: 2023 $559 · 2024 $916 · 2025 $484
Food & beverage: $484
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $168 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $67 |
| GENZYME CORPORATION | 2 | $64 |
| Lilly USA, LLC | 2 | $43 |
| ABBVIE INC. | 2 | $40 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $34 |
| Amgen Inc. | 1 | $20 |
| PFIZER INC. | 1 | $17 |
| Incyte Corporation | 1 | $17 |
| Janssen Biotech, Inc. | 1 | $14 |
Products named: COSENTYX, DUPIXENT, ILUMYA, Rhapsido, TALTZ, BOTOX, Otezla, EBGLYSS.
Industry payments across AR — which companies pay providers there.
